ImageWare Systems, Inc. (ImageWare) (OTCQB: IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, today introduced GoVerifyID® Enterprise Suite, an innovative, multi-modal, multi-factor biometric authentication solution for the enterprise market. An algorithm-agnostic solution, GoVerifyID Enterprise Suite is the first ever end-to-end biometric platform that seamlessly integrates with an enterprise’s existing Microsoft infrastructure, offering businesses a turnkey biometric solution for quick deployment in an afternoon or less.
“Last year nearly 80 percent of businesses reported a data breach. As the digital workforce expands, with data extended to external stakeholders and across numerous types of devices and systems, the need for high-assurance, enterprise-wide protection has intensified,” said Jim Miller, chairman & CEO of ImageWare. “The traditional security perimeters have changed and executives are being held accountable for safeguarding data against potentially devastating breaches that can tarnish a brand’s reputation. Armed with GoVerifyID Enterprise Suite, corporations have access to a scalable and affordable solution that works with their existing Microsoft infrastructure and gives them the ultimate peace of mind.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7978451-imageware-goverifyid-enterprise-suite/
The American Cancer Society and the CVS Health Foundation today awarded grants to 20 U.S. colleges and universities as part of their Tobacco-Free Generation Campus Initiative (TFGCI), a $3.6 million multi-year program intended to accelerate and expand the adoption and implementation of 100 percent smoke- and tobacco-free campus policies. The announcement coincides this week with the American Cancer Society Great American Smokeout.
The Tobacco-Free Generation Campus Initiative is part of Be The First, CVS Health's five-year, $50 million initiative that supports education, advocacy, tobacco control, and healthy behavior programming to help deliver the nation’s first tobacco-free generation. CVS Health has set actionable and measurable goals for Be The First, including a doubling of the number of tobacco-free college and university campuses in the United States.
To view the multimedia release go to:
http://www.multivu.com/players/English/7963951-cvs-health-tobacco-free-campus/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
The health of babies in the United States has taken a step backward as the nation’s preterm birth rate worsened for the first time in eight years, the March of Dimes said today. The U.S. earned a “C” grade on the latest March of Dimes Premature Birth Report Card amidst widening differences in prematurity rates across different races and ethnicities.
“The 2016 March of Dimes Report Card demonstrates that there is an unfair burden of premature birth among specific racial and ethnic groups as well as geographic areas,” says Dr. Jennifer L. Howse, president of the March of Dimes. “The March of Dimes strives for a world where every baby has a fair chance, yet we see this is not the reality for many mothers and babies. Babies in this country have different chances of surviving and thriving simply based on the circumstances of their birth.”
The U.S. preterm birth rate went up from 9.57 to 9.63 in 2015, according to final data from the National Center for Health Statistics (NCHS). Across the country, preterm birth rates were nearly 48 percent higher among black women and more than 15 percent higher among American Indian/Alaska Native women compared to white women.
To view the multimedia release go to:
http://www.multivu.com/players/English/7945951-march-of-dimes-premature-birth-report/
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
As called for in the President’s Cybersecurity National Action Plan, the White House, the National Cyber Security Alliance (NCSA) and more than 35 companies and NGOs today announced a new internet safety and security campaign, “Lock Down Your Login,” to empower Americans to better protect their online accounts. The goal is to encourage a move beyond usernames and passwords to a widespread adoption of strong authentication for key online accounts. The majority of Americans (72 percent) believe their accounts are secure with just usernames and passwords. Usernames and passwords simply are not enough; hackers and cybercriminals continue to evolve their attack techniques, and users must improve their security to better protect their accounts.
The campaign is launching at a time when Americans are more connected than ever: 73 percent go online daily, and one in five are constantly connected. Coupled with increased connectivity are high levels of concern about identity theft, device security and risks such as phishing. In fact, a recent NCSA/Microsoft study found that preventing identity theft is the top online safety topic that both U.S. adults and teens (ages 13-17) would like to learn more about. Additionally, teens reported that unauthorized account access is their top online safety concern. Although Americans consistently express high levels of concern about identity theft, device security and risks such as phishing, many are either not aware or not using widely available, simple technologies to better secure their online accounts. Americans expect the cybersecurity community to help solve the problem. In another study, 78 percent of Americans reported they strongly or somewhat agree that government, industry and other stakeholders should work to find new ways of securing accounts beyond the password.
To view the multimedia release go to:
http://www.multivu.com/players/English/7934951-ncsa-lock-down-your-login-cyber-security/
Approximately 153,000 students across the country in grades K–12 cast their ballots in the 2016 Scholastic News® Student Vote and the results are in: Democratic presidential candidate Hillary Clinton has been named the winner, with 52% of the student vote while Republican candidate Donald Trump received 35%. Thirteen percent of student voters wrote in “other” choices, a larger percentage than in past presidential elections. Write-in votes were cast for Libertarian Party candidate Gary Johnson (2%), Senator Bernie Sanders (1%), and Green Party candidate Jill Stein (1%), along with “Mom,” Kanye West, Harambe the gorilla, Spider-Man and “bacon.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7936951-scholastic-news-presidential-election-student-vote/
Saving 30 percent up-front on the cost of attractive and functional home improvement products, as well as installation costs, and then saving on annual energy costs by utilizing solar power, is an attractive opportunity for homeowners.
Skylights provide natural light and ventilation
Energy Star-qualified no leak solar powered fresh air skylights from VELUX America offer that opportunity. The 30 percent federal tax credit on products and installation can make these top-of-the-line skylights available for close to the cost of entry-level models. The skylights not only admit healthful natural light, but silently bring fresh air into the home to improve indoor air quality.
To view the multimedia release go to:
http://www.multivu.com/players/English/7920352-velux-solar-powered-skylights-tax-credit/
BabyCenter.com, the #1 pregnancy and parenting digital resource, today released its 2016 U.S. Cost of Raising a Child report, which examines the rising cost of having a baby. More than 1,100 BabyCenter moms completed the survey, which found that parents spend an average of $13,000 per year on each child.
In 2016, 7 out of 10 moms say they are worried about having enough money to raise their kids – a 5 percent increase since last year. BabyCenter also found that 9 out of 10 moms are in debt and nearly 4 in 10 don’t see a day when they will be entirely debt free. Also, 1 in 4 is receiving financial aid from a parent or family member, and 1 in 3 is experiencing relationship issues with their partner due to working longer or irregular hours.
To view the multimedia release go to:
http://www.multivu.com/players/English/7700853-babycenter-cost-of-raising-a-child-report/
Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
Progresso is now using only 100 percent antibiotic and hormone free chicken breasts in all of its 36 chicken soup varieties. Currently available on store shelves nationwide, Progresso is the first large retail soup brand in the United States to have antibiotic and hormone free chicken breasts in its soups.
For decades, Progresso has been committed to continuously improving the quality of its soups. Not only is Progresso now using only white breast meat chicken with no antibiotics or hormones, but the brand is also free from artificial flavors and has removed artificial colors from 60 percent of its soups, with a goal to remove 100 percent by 2019. In addition, the soup brand has reduced sodium levels in more than 40 soup varieties, added seven soups to its certified Gluten Free product line and is increasing its vegetarian soup options.
To view the multimedia release go to:
http://www.multivu.com/players/English/7885251-progresso-antibiotic-free-chicken/
International Connections Academy, an accredited online private school for students in grades K-12, is making it easier for families moving or currently living abroad to transition their children to school anywhere in the world through its new online education resource for expat families.
International Connections Academy currently serves students in more than 40 countries across the globe – with the number of expat families it serves growing each semester. The school’s 2016 Parent Satisfaction Survey recently revealed that 80 percent of currently enrolled families living abroad moved for business purposes, with two-thirds planning on living in their new country for at least four years.
To view the multimedia release go to:
http://www.multivu.com/players/English/7654354-international-connections-academy-education-abroad/
